366 related articles for article (PubMed ID: 18756966)
1. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
Li MR; Jiang K; Zhang QY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):957-60. PubMed ID: 18756966
[TBL] [Abstract][Full Text] [Related]
2. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
[TBL] [Abstract][Full Text] [Related]
3. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome].
Kong WM; Gong J; Dong L; Xu JR
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1345-7. PubMed ID: 17884774
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
[TBL] [Abstract][Full Text] [Related]
5. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
[TBL] [Abstract][Full Text] [Related]
6. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
7. Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.
Katinios G; Casado-Bedmar M; Walter SA; Vicario M; González-Castro AM; Bednarska O; Söderholm JD; Hjortswang H; Keita ÅV
Inflamm Bowel Dis; 2020 Jun; 26(7):974-984. PubMed ID: 31944236
[TBL] [Abstract][Full Text] [Related]
8. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of mucosal beta-defensin-2, TNFalpha and IL-1beta in ulcerative colitis].
Chang YY; Ouyang Q
Zhonghua Nei Ke Za Zhi; 2008 Jan; 47(1):11-4. PubMed ID: 18346318
[TBL] [Abstract][Full Text] [Related]
10. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
[TBL] [Abstract][Full Text] [Related]
11. Expression of aquaporin 8 in colonic epithelium with diarrhoea-predominant irritable bowel syndrome.
Wang JP; Hou XH
Chin Med J (Engl); 2007 Feb; 120(4):313-6. PubMed ID: 17374283
[TBL] [Abstract][Full Text] [Related]
12. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
Gecse K; Róka R; Séra T; Rosztóczy A; Annaházi A; Izbéki F; Nagy F; Molnár T; Szepes Z; Pávics L; Bueno L; Wittmann T
Digestion; 2012; 85(1):40-6. PubMed ID: 22179430
[TBL] [Abstract][Full Text] [Related]
13. [Signal transduction pathway of colonic Toll-like receptor 4 in patients with irritable bowel syndrome].
Wang XM; Liu YL
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3415-7. PubMed ID: 19159572
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.
Katsuta T; Lim C; Shimoda K; Shibuta K; Mitra P; Banner BF; Mori M; Barnard GF
Am J Gastroenterol; 2000 Nov; 95(11):3157-64. PubMed ID: 11095335
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
Akazawa A; Sakaida I; Higaki S; Kubo Y; Uchida K; Okita K
J Gastroenterol; 2002; 37(5):345-53. PubMed ID: 12051533
[TBL] [Abstract][Full Text] [Related]
16. [Phenotypic analysis of Th cells in colon and peripheral blood in patients with irritable bowel syndrome].
Fu Y; Tong JJ; Pan Q; Wang WF; Zou KF; Qian W; Hou XH
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2120-3. PubMed ID: 20058616
[TBL] [Abstract][Full Text] [Related]
17. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice.
Annaházi A; Gecse K; Dabek M; Ait-Belgnaoui A; Rosztóczy A; Róka R; Molnár T; Theodorou V; Wittmann T; Bueno L; Eutamene H
Pain; 2009 Jul; 144(1-2):209-17. PubMed ID: 19450926
[TBL] [Abstract][Full Text] [Related]
18. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
[TBL] [Abstract][Full Text] [Related]
19. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
Coëffier M; Gloro R; Boukhettala N; Aziz M; Lecleire S; Vandaele N; Antonietti M; Savoye G; Bôle-Feysot C; Déchelotte P; Reimund JM; Ducrotté P
Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
Róka R; Rosztóczy A; Leveque M; Izbéki F; Nagy F; Molnár T; Lonovics J; Garcia-Villar R; Fioramonti J; Wittmann T; Bueno L
Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
